Cost analysis of diabetes treatment with glargine insulin or NPH insulin in Spain

被引：0

作者：

Rubio-Terrés, C

Rodriguez, J

Bolinder, B

机构：

[1] Aventis Pharma SA, Madrid, Spain

[2] Aventis Pharmaceut, Bridgewater, NJ USA

来源：

VALUE IN HEALTH | 2003年 / 6卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)64190-3

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：336 / 336

页数：1

共 50 条

[1] Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain
Terrés, CR
Rodríguez, J
Bolinder, B
de Pablos, P
DIABETOLOGIA, 2004, 47 : A345 - A345
[2] Cost-utility analysis of insulin glargine compared with NPH insulin in patients with type 1 diabetes in Spain
Terrés, CR
Rodríguez, J
Bolinder, B
De Pablos, P
DIABETES, 2004, 53 : A291 - A292
[3] Pharmacoeconomic analysis of insulin glargine compared with NPH insulin in patients with type 2 diabetes in Spain
Terres, CR
Rodríguez, J
Bolinder, B
De Pablos, P
DIABETES, 2004, 53 : A291 - A291
[4] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK
McEwan, Phil
Poole, Chris D.
Tetlow, Tony
Holmes, Paul
Currie, Craig J.
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S7 - S19
[5] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK
McEwan, Phil
Poole, Chris D.
Tetlow, Tony
Holmes, Paul
Currie, Craig J.
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S21 - S31
[6] Economic evaluation of the use of insulin glargine compared with NPH insulin in patients with Type 2 diabetes in Spain
Rodríguez, J
Terrés, CR
Bolinder, B
de Pablos, P
DIABETOLOGIA, 2004, 47 : A344 - A344
[7] Diabetes in Pregnancy: A Meta-Analysis of the Safety of Insulin Glargine Compared with NPH Insulin
Lepercq, Jacques
Lin, Jay
Hall, Gillian
Dain, Marie-Paule
Riddle, Matthew
Home, Philip
DIABETES, 2011, 60 : A259 - A260
[8] Insulin glargine versus NPH insulin in patients with type 1 diabetes
Ratner, R
DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
[9] The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 1 diabetes
McEwan, P.
Poole, C. D.
Holmes, P.
Tetlow, A. P.
Currie, C. J.
VALUE IN HEALTH, 2006, 9 (06) : A225 - A226
[10] Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies
Duckworth, William
Davis, Stephen N.
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (03) : 196 - 204

← 1 2 3 4 5 →